4-hydroxyphenylglycine has been researched along with Cardiac Hypertrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, GM; Hauton, D | 1 |
| Greaves, P; Martin, J; Michel, MC; Mompon, P | 1 |
| Faccini, JM; Greaves, P; Higgins, AJ | 1 |
3 other study(ies) available for 4-hydroxyphenylglycine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Cardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Biological Transport; Cardiomegaly; Cardiotonic Agents; Cold Temperature; Diet, High-Fat; Enzyme Inhibitors; Fatty Acids; Gene Expression; Glycine; Heart; Immunoblotting; In Vitro Techniques; Isoproterenol; Lipids; Lipoprotein Lipase; Myocardium; Rats; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Triglycerides | 2012 |
Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism.
Topics: Animals; Body Weight; Cardiomegaly; Dogs; Female; Glycine; Male; Myocardium; Rats; Rats, Inbred Strains; Species Specificity | 1984 |
Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation | 1985 |